What is the clinical evidence from this study?

Population: Troponin I myopathy. Intervention: D53 (S185F) mutation of the tropomyosin-2 (Tm2) gene. Primary outcome: Phenotypic effects of held-up(2) allele.

What question did this study set out to answer?

To determine how a suppressor mutation in the tropomyosin-2 gene rescues severe muscle defects caused by a mutant troponin I allele in Drosophila melanogaster.

May 1, 2001Molecular Biology of the CellOpen Access

A Tropomyosin-2 Mutation Suppresses a Troponin I Myopathy inDrosophila

View Full Paper

Ask AI

Bookmark

Key result

The D53 (S185F) missense mutation in the tropomyosin-2 gene fully suppressed the phenotypic effects of the held-up(2) Troponin I myopathy in Drosophila.

Key Points

To determine how a suppressor mutation in the tropomyosin-2 gene rescues severe muscle defects caused by a mutant troponin I allele in Drosophila melanogaster.
Identified and sequenced the D53 missense mutation (S185F) located in the tropomyosin-2 (Tm2) gene.
Evaluated physiological suppression in held-up(2) mutant flies by assaying indirect flight muscle integrity, adult jumping and flight performance, walking ability, larval behavior, and age-dependent myofibrillar structure.
The S185F mutation fully suppressed the phenotypic defects of held-up(2), eliminating flight muscle hypercontraction and restoring larval mobility, feeding behavior, and adult jumping ability.
Rescued flies exhibited a progressive, age-dependent loss of flight ability linked to a central structural collapse of the myofibrillar lattice near a troponin T binding domain.

Structured PICO

Population

Drosophila melanogaster with the held-up(2) allele of the Troponin I (wupA) gene

Exposure

D53 suppressor mutation (S185F missense mutation of the tropomyosin-2, Tm2, gene)

Outcome

Phenotypic effects including hypercontraction of indirect flight muscles, jumping, walking muscle myopathy, and larval crawling/feeding behavior

A specific tropomyosin-2 mutation in Drosophila suppresses troponin I myopathy, providing insights into muscle function and potential parallels with human familial hypertrophic cardiomyopathy.

Discussion

No takes yet. Share an insight, caveat, or question.

Implication

No immediate clinical implications for human myopathies; leaves open whether tropomyosin-2 variants modulate troponin I dysfunction.

Cite This Study

Naïmi et al. (2001) studied Troponin I myopathy. D53 (S185F) mutation of the tropomyosin-2 (Tm2) gene was evaluated on Phenotypic effects of held-up(2) allele. The D53 (S185F) missense mutation in the tropomyosin-2 gene fully suppressed the phenotypic effects of the held-up(2) Troponin I myopathy in Drosophila.

synapsesocial.com/papers/6a665fefde7593c004ad9ec1 https://doi.org/10.1091/mbc.12.5.1529

View Full Paper

Ask AI

Bookmark

A Tropomyosin-2 Mutation Suppresses a Troponin I Myopathy inDrosophila

Key Points

Structured PICO

Discussion

Implication

Cite This Study

A Tropomyosin-2 Mutation Suppresses a Troponin I Myopathy inDrosophila

Key Points

Structured PICO

Discussion

Implication

Cite This Study

Also Consider

Also Consider